Spontaneous tumour regression is a rare and poorly understood phenomenon and the described case may indicate that SGLT-2 inhibitors can cause HCC regression by inhibiting angiogenesis [153]. The gene discussed is SLC5A2; the disease is hepatocellular carcinoma.